| Ucb S.a. | 130K | US$39M | 5.2% |
| Abbvie Inc. | 125K | US$31.5M | 4.2% |
| Eli Lilly And Company | 26,000 | US$31.2M | 4.2% |
| Regeneron Pharmaceuticals, Inc. | 47,000 | US$29.3M | 3.9% |
| Unitedhealth Group Incorporated | 70,000 | US$29.1M | 3.9% |
| Pfizer, Inc. | 1.2M | US$28.8M | 3.8% |
| Merck & Company, Inc. | 215K | US$27.6M | 3.7% |
| Gilead Sciences, Inc. | 210K | US$26.5M | 3.5% |
| Astrazeneca Plc | 131K | US$24.5M | 3.3% |
| Elevance Health, Inc. | 63,000 | US$24.4M | 3.2% |
| Chugai Pharmaceutical Co., Ltd. | 450K | US$20.8M | 2.8% |
| Viatris Inc. | 1.17M | US$18.6M | 2.5% |
| Oruka Therapeutics, Inc. | 190K | US$18.1M | 2.4% |
| Halozyme Therapeutics, Inc. | 220K | US$17.2M | 2.3% |
| Amgen Inc. | 47,000 | US$17M | 2.3% |
| Illumina, Inc. | 90,000 | US$15.8M | 2.1% |
| Alkermes Plc | 260K | US$13.6M | 1.8% |
| Viking Therapeutics, Inc. | 330K | US$12.9M | 1.7% |
| Vertex Pharmaceuticals Incorporated | 25,000 | US$12.4M | 1.7% |
| Roivant Sciences Ltd. | 338K | US$12M | 1.6% |
| Neurocrine Biosciences, Inc. | 70,000 | US$11.8M | 1.6% |
| Arcus Biosciences, Inc. | 379K | US$11.7M | 1.6% |
| Zimmer Biomet Holdings, Inc. | 124K | US$10.7M | 1.4% |
| Boston Scientific Corporation | 250K | US$10.7M | 1.4% |
| Sanofi Sa | 120K | US$10.3M | 1.4% |
| Uniqure N.v. | 218K | US$10M | 1.3% |
| Stryker Corporation | 30,000 | US$9.45M | 1.3% |
| Incyte Corporation | 80,000 | US$9.07M | 1.2% |
| Alnylam Pharmaceuticals, Inc. | 30,000 | US$9.03M | 1.2% |
| Cogent Biosciences, Inc. | 230K | US$8.9M | 1.2% |
| Medtronic Plc. | 100K | US$7.82M | 1.0% |
| Cvs Health Corporation | 75,000 | US$7.76M | 1.0% |
| Abbott Laboratories | 80,000 | US$7.26M | 0.97% |
| Quest Diagnostics Incorporated | 30,000 | US$6.36M | 0.85% |
| Anaptysbio, Inc. | 93,732 | US$6.33M | 0.84% |
| Tarsus Pharmaceuticals, Inc. | 100K | US$6.29M | 0.84% |
| Rigel Pharmaceuticals, Inc. | 160K | US$6.26M | 0.83% |
| Biogen Inc. | 28,000 | US$6.05M | 0.81% |
| Grail, Inc. | 85,000 | US$5.8M | 0.77% |
| Biomarin Pharmaceutical Inc. | 100K | US$5.72M | 0.76% |
| Vir Biotechnology, Inc. | 500K | US$5.09M | 0.68% |
| Johnson & Johnson | 20,000 | US$5.08M | 0.68% |
| Monte Rosa Therapeutics, Inc. | 200K | US$4.84M | 0.65% |
| Immunovant, Inc. | 122K | US$4.7M | 0.63% |
| Abivax Sa | 30,000 | US$4M | 0.53% |
| Syndax Pharmaceuticals, Inc. | 180K | US$3.93M | 0.52% |
| Madrigal Pharmaceuticals, Inc. | 7,000 | US$3.76M | 0.50% |
| Theravance Biopharma, Inc. | 209K | US$3.55M | 0.47% |
| Xencor, Inc. | 200K | US$3.22M | 0.43% |
| Perrigo Company Plc | 230K | US$2.39M | 0.32% |
| Acadia Pharmaceuticals Inc. | 92,648 | US$2.34M | 0.31% |
| Ultragenyx Pharmaceutical Inc. | 70,000 | US$2.34M | 0.31% |
| Compugen Ltd. | 1.02M | US$2.18M | 0.29% |
| Moonlake Immunotherapeutics | 110K | US$2.14M | 0.29% |
| Macrogenics, Inc. | 420K | US$1.94M | 0.26% |
| First Tracks Biotherapeutics, Inc. | 93,732 | US$1.89M | 0.25% |
| Regenxbio Inc. | 149K | US$1.79M | 0.24% |
| United Therapeutics Corporation | 3,000 | US$1.63M | 0.22% |
| Arvinas, Inc. | 180K | US$1.5M | 0.20% |
| Moderna, Inc. | 20,000 | US$1.4M | 0.19% |
| Cytokinetics, Incorporated | 15,000 | US$1.28M | 0.17% |
| Coherus Oncology, Inc. | 900K | US$1.26M | 0.17% |
| Nektar Therapeutics | 17,092 | US$1.19M | 0.16% |
| Janux Therapeutics, Inc. | 76,601 | US$1.18M | 0.16% |
| Vaxcyte, Inc. | 20,000 | US$1.16M | 0.15% |
| Proqr Therapeutics N.v. | 620K | US$1.15M | 0.15% |
| Cosmo Pharmaceuticals Nv | 14,000 | US$1.15M | 0.15% |
| Cellectis S.a. | 227K | US$681K | 0.09% |
| Olema Pharmaceuticals, Inc. | 50,000 | US$626K | 0.08% |
| Viridian Therapeutics, Inc. | 29,370 | US$540K | 0.07% |
| Puma Biotechnology Inc | 61,255 | US$497K | 0.07% |
| Wave Life Sciences Ltd. | 81,955 | US$476K | 0.06% |
| Organon & Co. | 29,500 | US$399K | 0.05% |
| Instil Bio, Inc. | 50,000 | US$385K | 0.05% |
| Intellia Therapeutics, Inc. | 20,000 | US$338K | 0.05% |
| Karyopharm Therapeutics Inc. | 33,333 | US$326K | 0.04% |
| Atea Pharmaceuticals, Inc. | 70,000 | US$326K | 0.04% |
| Allogene Therapeutics, Inc. | 147K | US$305K | 0.04% |
| Altimmune, Inc. | 100K | US$304K | 0.04% |
| Myriad Genetics, Inc. | 50,000 | US$286K | 0.04% |
| Rocket Pharmaceuticals, Inc. | 58,000 | US$198K | 0.03% |
| Sarepta Therapeutics, Inc. | 11,000 | US$198K | 0.03% |
| Phio Pharmaceuticals Corp. | 50,000 | US$51,250 | <0.01% |
| Lite Strategy, Inc. | 30,000 | US$27,672 | <0.01% |
| Innocare Pharma Ltd. Class A | 17,000 | US$25,771 | <0.01% |
| Sangamo Therapeutics, Inc. | 400K | US$21,560 | <0.01% |
| Fortress Biotech, Inc. | 6,666 | US$20,398 | <0.01% |
| Nextcure, Inc. | 12,500 | US$20,000 | <0.01% |
| Voyager Therapeutics, Inc. | 5,700 | US$19,950 | <0.01% |
| Euroapi Sa | 8,695 | US$13,263 | <0.01% |
| Galmed Pharmaceuticals Ltd. | 1,701 | US$946 | <0.01% |
| Mustang Bio, Inc. | 160 | US$112 | <0.01% |
| Xoma Royalty Corporation | 0 | US$0 | 0.00% |